ImCare Biotech

Drugs, Diagnostics

IMB102 RD oncology; Seravue Clin? liver cancer diagnostic

ImCare Biotech is a clinical-stage biotechnology company developing innovative diagnostic biomarkers and developmental drugs for the treatment of liver diseases such as hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). The company's mission is to provide quality diagnostic and pharmaceutical products for the treatment of cancers, viral infections, and other long-term illnesses and improve the standard of care for patients and their loved ones. ImCare Biotech's lead product candidate, IMC-01, is a diagnostic biomarker for the early detection of HCC. IMC-01 is a non-invasive blood test that can detect HCC with high sensitivity and specificity.